SCHEMBL3615673

SCHEMBL3615673

CCOC(=S)SC(C(=O)O)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP2D6 P10635 1/20 0.46
HDAC3 O15379 2/20 0.32
HDAC4 P56524 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC7 Q8WUI4 2/20 0.32
HDAC2 Q92769 2/20 0.32
HDAC10 Q969S8 2/20 0.32
HDAC11 Q96DB2 2/20 0.32
HDAC8 Q9BY41 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
HDAC9 Q9UKV0 2/20 0.32
HDAC5 Q9UQL6 2/20 0.32
LMNA P02545 1/20 0.31
HSD17B10 Q99714 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31
ALOX15 P16050 1/20 0.30
MGAM O43451 1/20 0.30
GAA P10253 1/20 0.30
SI P14410 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18113181 0.80 ALDH1A1 (0.38) ALDH1A1CYP2D6MMP8
SCHEMBL264599 0.76 ALDH1A1 (0.50) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL3453217 0.74 ALDH1A1 (0.41) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL3108145 0.71 ALDH1A1 (0.50) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL238094 0.69 ALDH1A1 (0.47) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL24981804 0.68 ALDH1A1 (0.46) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL13007081 0.68 ALDH1A1 (0.50) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL17212355 0.68 ALDH1A1 (0.46) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL5316195 0.68 ALDH1A1 (0.46) ALDH1A1CYP2D6HDAC3HDAC4HDAC1
SCHEMBL264829 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035917-A1 PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INHIBITORS GLAXO GROUP LIMITED (GB) 2010-02-11 US disclosed
US-20080176891-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2008-07-24 US disclosed
US-20080146606-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2008-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176891-A1 NOVEL COMPOUNDS NFKBIA, IKBKG, IKBKE ALDH1A1 4154/4885CYP2D6 2745/4885HDAC3 1351/4885
US-20100035917-A1 PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INHIBITORS PLK2, PDXK, MAP4K2 ALDH1A1 2180/4885CYP2D6 2573/4885HDAC3 1887/4885
US-20080146606-A1 NOVEL COMPOUNDS NFKBIA, IKBKG, IKBKE ALDH1A1 4154/4885CYP2D6 2745/4885HDAC3 1351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.